Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis
This study is currently recruiting participants.
Study NCT00004489   Information provided by FDA Office of Orphan Products Development
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoporosis
Cystic Fibrosis
Additional conditions recognized in this trial
Fibrosis
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Digestive System Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases
Lung Diseases
Musculoskeletal Diseases
Pancreatic Diseases
Pathologic Processes
Respiratory Tract Diseases
Interventions listed in this trial
alendronate sodium
calcium carbonate
cholecalciferol
Additional drug interventions recognized in this trial
Alendronate
More general drug interventions related to this trial
Antacids
Bone Density Conservation Agents
Growth Substances
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Vitamins
Sponsors listed in this trial
FDA Office of Orphan Products Development
University of North Carolina


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services